Dan Brennan
Stock Analyst at TD Cowen
(4.31)
# 396
Out of 5,127 analysts
126
Total ratings
54.64%
Success rate
16.28%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Maintains: Buy | $654 → $696 | $615.27 | +13.12% | 14 | Jan 7, 2026 | |
| ILMN Illumina | Maintains: Hold | $115 → $140 | $147.08 | -4.81% | 14 | Jan 7, 2026 | |
| DHR Danaher | Maintains: Buy | $260 → $270 | $236.24 | +14.29% | 7 | Jan 7, 2026 | |
| BRKR Bruker | Maintains: Hold | $42 → $53 | $52.21 | +1.51% | 3 | Jan 7, 2026 | |
| TXG 10x Genomics | Maintains: Hold | $15 → $18 | $19.42 | -7.31% | 5 | Jan 7, 2026 | |
| AVTR Avantor | Maintains: Hold | $14 → $12 | $12.21 | -1.72% | 4 | Jan 7, 2026 | |
| MDXH MDxHealth | Maintains: Buy | $5 → $7 | $3.35 | +108.96% | 2 | Nov 13, 2025 | |
| WAT Waters | Maintains: Hold | $345 → $390 | $398.01 | -2.01% | 4 | Nov 5, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $74 → $90 | $101.72 | -11.52% | 7 | Nov 4, 2025 | |
| MYGN Myriad Genetics | Maintains: Hold | $8 → $9 | $6.50 | +38.46% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $162 | $147.40 | +9.91% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $63 → $72 | $106.97 | -32.69% | 3 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $12.76 | -5.96% | 7 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $15.83 | -5.24% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $28.67 | +11.61% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $110 | $136.50 | -19.41% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $2.5 | $3.82 | -34.55% | 4 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $74 | $68.64 | +7.81% | 2 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $175 | $233.78 | -25.14% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $250 | $213.37 | +17.17% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $141 → $144 | $102.49 | +40.50% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $40.66 | +25.43% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $56 | $5.75 | +873.91% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $216.27 | +152.46% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $2.06 | +628.16% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $186.29 | +24.54% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,471.39 | -40.19% | 3 | Oct 7, 2020 |
Thermo Fisher Scientific
Jan 7, 2026
Maintains: Buy
Price Target: $654 → $696
Current: $615.27
Upside: +13.12%
Illumina
Jan 7, 2026
Maintains: Hold
Price Target: $115 → $140
Current: $147.08
Upside: -4.81%
Danaher
Jan 7, 2026
Maintains: Buy
Price Target: $260 → $270
Current: $236.24
Upside: +14.29%
Bruker
Jan 7, 2026
Maintains: Hold
Price Target: $42 → $53
Current: $52.21
Upside: +1.51%
10x Genomics
Jan 7, 2026
Maintains: Hold
Price Target: $15 → $18
Current: $19.42
Upside: -7.31%
Avantor
Jan 7, 2026
Maintains: Hold
Price Target: $14 → $12
Current: $12.21
Upside: -1.72%
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $3.35
Upside: +108.96%
Waters
Nov 5, 2025
Maintains: Hold
Price Target: $345 → $390
Current: $398.01
Upside: -2.01%
Exact Sciences
Nov 4, 2025
Maintains: Buy
Price Target: $74 → $90
Current: $101.72
Upside: -11.52%
Myriad Genetics
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $9
Current: $6.50
Upside: +38.46%
Oct 14, 2025
Maintains: Buy
Price Target: $150 → $162
Current: $147.40
Upside: +9.91%
Sep 25, 2025
Maintains: Buy
Price Target: $63 → $72
Current: $106.97
Upside: -32.69%
Sep 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $12.76
Upside: -5.96%
Aug 6, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $15.83
Upside: -5.24%
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $28.67
Upside: +11.61%
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $136.50
Upside: -19.41%
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $3.82
Upside: -34.55%
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $68.64
Upside: +7.81%
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $233.78
Upside: -25.14%
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $213.37
Upside: +17.17%
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $102.49
Upside: +40.50%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $40.66
Upside: +25.43%
May 13, 2024
Initiates: Buy
Price Target: $56
Current: $5.75
Upside: +873.91%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $216.27
Upside: +152.46%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $2.06
Upside: +628.16%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $186.29
Upside: +24.54%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,471.39
Upside: -40.19%